Dr. Arash Dehkordi is a physician-scientist and Visiting Researcher at Imperial College London. His research focuses on translational approaches to pancreatic and liver diseases, including cancer, liver failure, and metabolic liver disorders. He works on gene therapy, RNA-based therapeutics, targeted delivery systems, and biomarker-driven precision medicine. Dr. Dehkordi also serves as Chief Medical Officer of Dawn Therapeutics, supporting the development of innovative therapeutic platforms.
Join Congress 2026